ACE and diabetes mellitus: No significant differences in the use of other therapeutic medications were found between the two groups, except for greater use of oral anti-diabetes drugs and angiotensin-converting enzyme inhibitors/angiotensin receptor blockages at discharge in patients with BMI ≥ 25 kg/m2.